Bausch starts study for dry eye disease linked with Meibomian Gland Dysfunction
Bausch Health Companies Inc and its global eye health business Bausch + Lomb have announced that the second of two Phase 3 studies evaluating...
FlowMetric introduces ‘breakthrough’ Covid-19 antibody test
FlowMetric has launched a 'powerful advancement' in Covid-19 antibody testing that the company said delivers exceptional performance compared to existing tests on the global...
Oramed Pharmaceuticals Inc starts Phase 3 Trial of Oral Insulin
Oramed Pharmaceuticals Inc announced that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for...
Timely detection and prevention of Thalassemia stressed in India
Apurva Chandra, Secretary, Ministry of Health and Family Welfare stressed on the importance of timely detection and prevention of Thalassemia to tackle the disease....
Piramal Pharma Solutions on expansion mode, invests ~$32 Million
Piramal Pharma Solutions, a Piramal Pharma Limited business and a leading Contract Development and Manufacturing Organization (CDMO), has revealed its plans to expand its...
AstraZeneca starts Phase 2b clinical study of medicine to lower cholesterol: Ionis
Ionis Pharmaceuticals, Inc. has said that the AstraZeneca has commenced a Phase 2b clinical trial of ION449 (AZD8233).
It is an investigational antisense medicine designed...
Covid breakthrough: Baricitinib plus remdesivir show promising results in treating Corona infection
Covid treatment is no more a dream. In a relif to those who are waiting for Covid-19 medicine, it has emerged that combination of...
Daewoong, Sygnature Discovery eyes autoimmune disease research
South Korea-based Daewoong Pharmaceutical has entered a research collaboration with Sygnature Discovery to expand its global open innovation for novel drug development.
Daewoong Pharmaceutical enters...
Biocon Biologics gets $150 mn capital dose from Goldman Sachs
The Board of Biocon Biologics Ltd has approved a Rs 1,125 Crore (~USD 150 million) capital injection from Goldman Sachs.
Biocon Biologics is a subsidiary...
Bharat Biotech raises hopes to chase away Covid-19 as it commences Covaxin’s Phase III...
Hyderabad-based Bharat Biotech has said it has commenced Phase III trials of COVAXIN™ today (November 17, 2020).
According to the company, this exercise, conducted in...